SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-052535
Filing Date
2021-04-20
Accepted
2021-04-20 16:16:59
Documents
2
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm212671d1_pre14a.htm PRE 14A 459492
2 GRAPHIC tm212671d1_pre14aimg001.jpg GRAPHIC 7633
  Complete submission text file 0001104659-21-052535.txt   471299
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35366 | Film No.: 21838037
SIC: 2834 Pharmaceutical Preparations